For the half-year to 30 June 2014, the IPKat's regular team is supplemented by contributions from guest bloggers Alberto Bellan, Darren Meale and Nadia Zegze.

Two of our regular Kats are currently on blogging sabbaticals. They are David Brophy and Catherine Lee.

Thursday, 5 February 2009

EU pharma sector inquiry -- the IPI response

The Intellectual Property Institute has prepared a paper for the EU Commission in response to the DG Competition Inquiry into the pharmaceutical sector (on which see IPKat posts here and here). Since responses have not yet apparently been posted on the Commission website, the IPKat is taking the liberty of pinning the IPI's response here. This response reflects the efforts of Duncan Curley and Steve Smith, who had to work to a very tight time framework and who, all things considered, have done a pretty good job.


Right: the IPKat has his own opinion about pharmaceutical products, but for once he's keeping his mouth shut.

STOP PRESS: the IPKat has just received the response of the Intellectual Property Lawyers' Association (IPLA) to the same Inquiry.  You can read the IPLA response here.

2 comments:

goldenrail said...

That picture is so sad! Poor kitty...

Emily said...

and CIPA's response is here:

http://www.cipa.org.uk/download_files/CIPA_Response_to%20Pharma_Inquiry_Report.pdf

Subscribe to the IPKat's posts by email here

Just pop your email address into the box and click 'Subscribe':